Search Results Search Sort by RelevanceMost Recent Case and Commentary Sep 2008 Weighing the Duty to Inform a Patient of Possible Future Illness Shannon Sullivan, MD Approximately two-thirds of men aged 50 and older diagnosed REM sleep behavior disorder develop neurologic disease, for which there is no prevention or treatment at present. Virtual Mentor. 2008;10(9):553-555. doi: 10.1001/virtualmentor.2008.10.9.ccas3-0809. Case and Commentary Feb 2017 How Should Therapeutic Decisions about Expensive Drugs Be Made in Imperfect Environments? Leonard M. Fleck, PhD and Marion Danis, MD Clinicians can be patient advocates, resource stewards, and promote good financial choices about care. AMA J Ethics. 2017;19(2):147-156. doi: 10.1001/journalofethics.2017.19.2.ecas2-1702. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. State of the Art and Science Jan 2003 How to Change Routes of Administration of Opioids Audiey Kao, MD, PhD Virtual Mentor. 2003;5(1):19-20. doi: 10.1001/virtualmentor.2003.5.1.cprl1-0301. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 1 Melissa D. Colsman, MA and David E. Sandberg, PhD Virtual Mentor. 2005;7(11):727-732. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 2 David B. Allen, MD Virtual Mentor. 2005;7(11):732-735. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Dec 2005 Lead Paint Dangers and Physician Advocacy, Commentary 1 Lisa J. Chamberlain, MD, MPH Virtual Mentor. 2005;7(12):783-786. doi: 10.1001/virtualmentor.2005.7.12.ccas2-0512. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page Next › Last page Last »
Case and Commentary Sep 2008 Weighing the Duty to Inform a Patient of Possible Future Illness Shannon Sullivan, MD Approximately two-thirds of men aged 50 and older diagnosed REM sleep behavior disorder develop neurologic disease, for which there is no prevention or treatment at present. Virtual Mentor. 2008;10(9):553-555. doi: 10.1001/virtualmentor.2008.10.9.ccas3-0809.
Case and Commentary Feb 2017 How Should Therapeutic Decisions about Expensive Drugs Be Made in Imperfect Environments? Leonard M. Fleck, PhD and Marion Danis, MD Clinicians can be patient advocates, resource stewards, and promote good financial choices about care. AMA J Ethics. 2017;19(2):147-156. doi: 10.1001/journalofethics.2017.19.2.ecas2-1702.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
State of the Art and Science Jan 2003 How to Change Routes of Administration of Opioids Audiey Kao, MD, PhD Virtual Mentor. 2003;5(1):19-20. doi: 10.1001/virtualmentor.2003.5.1.cprl1-0301.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 1 Melissa D. Colsman, MA and David E. Sandberg, PhD Virtual Mentor. 2005;7(11):727-732. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 2 David B. Allen, MD Virtual Mentor. 2005;7(11):732-735. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Dec 2005 Lead Paint Dangers and Physician Advocacy, Commentary 1 Lisa J. Chamberlain, MD, MPH Virtual Mentor. 2005;7(12):783-786. doi: 10.1001/virtualmentor.2005.7.12.ccas2-0512.